June 6, 2016 by CC • Trade Ideas

Less than a two weeks ago we expressed a bullish view for healthcare stocks to play a bit of catch up with the S&P 500 (SPX) as it approached its prior all time highs, choosing …

Continue reading
April 25, 2016 by Dan • Commentary

For week’s now my co-panelist on CNBC’s Options Action, Carter Worth of Cornerstone Macro Research has been making the bullish case for the Biotech stocks, specifically looking at the IBB, the iShares Nasdaq Biotech etf. …

Continue reading
September 22, 2015 by Dan • Commentary

When market participants lack confidence in the underpinnings of the investment environment they quickly turn to technical analysis as their main trading input (there are some traditionalists with a long timer horizon that still view …

Continue reading
July 15, 2014 by Enis • Commentary

Back in March the biotechnology sector was hard hit hard alongside social media, solar and 3d printing. Since then, most of these sectors have recovered most of their losses from that sell-off. Which brings us …

Continue reading